Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria

NCT07378527 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

344

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Spontaneous Urticaria (CSU)

Interventions

DRUG: ICP-332 Tablets
DRUG: ICP-332 placebo Tablets
DRUG: ICP-332 Tablets

Sponsor

Beijing InnoCare Pharma Tech Co., Ltd.